Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam

European Journal of Pharmacology

Volumn 380, Issue 2-3, 1999, Pages 67-72

  Borowicz, Kinga K ^a   Luszczki, Jarogniew ^a   Szadkowski, Marcin ^a   Kleinrok, Zdzislaw ^a   Czuczwar, Stanislaw J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

AMPA kainate receptor; Amygdala kindled seizure; Clonazepam; Electroshock maximal; LY 300164; Pentylenetetrazol

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; AMPA RECEPTOR ANTAGONIST; CLONAZEPAM; KAINIC ACID RECEPTOR ANTAGONIST; PENTETRAZOLE; TALAMPANEL; UNCLASSIFIED DRUG;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; FOCAL EPILEPSY; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

AMYGDALA; ANIMALS; ANTICONVULSANTS; ATAXIA; AVOIDANCE LEARNING; BENZODIAZEPINES; CLONAZEPAM; DRUG SYNERGISM; ELECTROSHOCK; EXCITATORY AMINO ACID ANTAGONISTS; KINDLING, NEUROLOGIC; MALE; MICE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; RECEPTORS, AMPA; SEIZURES; SPECIES SPECIFICITY;

EID: 0032872484     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00541-5     Document Type: Article

References (23)

1. Borowicz K.K., Gasior M., Kleinrok Z., Czuczwar S.J. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur. J. Pharmacol. 281:1995;319-326.
2. Czuczwar S.J., Turski W.A., Kleinrok Z. Interactions of excitatory amino acid antagonists with conventional antiepileptic drugs. Metab. Brain. Dis. 11:1996;143-152.
3. Czuczwar S.J., Turski W.A., Kleinrok Z. Interaction of calcium channel blockers and excitatory amino acid antagonists with conventional antiepileptic drugs. CNS Drug Res. 2:1996;452-467.
4. Czuczwar S.J., Świa̧der M., Kuźniar H., Gasior M., Kleinrok Z. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Eur. J. Pharmacol. 359:1998;103-109.
5. Czuczwar S.J., Kamiński R., Gasior M., Kozicka M., Zawadzki A., Kleinrok Z. LY 300164, a novel non-NMDA receptor antagonist, potentiates the anticonvulsive activity of antiepileptic drugs. Korczyn A.D. 4th Congress of the European Society for Clinical Neuropharmacology, Eilat, Israel, December 1-4, 1997. 1998;35-39 Monduzzi Editore, Bologna.
6. DeLorenzo R.J. Mechanisms of action of anticonvulsant drugs. Epilepsia. 29(Suppl. 2):1988;S35-S47.
7. Dürmüller N., Graggs M., Meldrum B.S. The effect of the non-NMDA receptor antagonists GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res. 17:1994;167-174.
8. Goddard G., McIntyre D., Leech C. A permanent change in brain function resulting from daily electrical stimulation. Exp. Neurol. 25:1986;295-330.
9. Litchfield J.T., Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 96:1949;99-113.
10. Löscher W. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy. Prog. Neurobiol. 54:1998;721-741.
11. Löscher W., Hönack D. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine. J. Pharmacol. Exp. Ther. 256:1991;432-440.
12. Löscher W., Hönack D. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil. Br. J. Pharmacol. 113:1994;1349-1357.
13. Löscher W., Schmidt D. Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations. Epilepsy Res. 2:1988;145-181.
14. Löscher W., Jäckel R., Czuczwar S.J. Is amygdala-kindling in rats a model for drug-resistant partial epilepsy? Exp. Neurol. 93:1986;211-226.
15. A receptors. FASEB J. 4:1990;1469-1480.
16. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. 1986;Academic Press, Sydney.
17. Racine R.J. Modification of seizure activity by electrical stimulation: II. Motor seizure. Electroencephalogr. Clin. Neurophysiol. 32:1972;281-294.
18. Rosenberg H.C., Tietz E.I., Chiu T.H. Tolerance to anticonvulsant effects of diazepam, clonazepam, and clobazam in amygdala-kindled rats. Epilepsia. 30:1989;276-285.
19. Schmutz M., Klebs K., Baltzer V. Inhibition or enhancement of kindling evolution by antiepileptics. J. Neural Transm. 72:1988;245-257.
20. Tietz E.I., Gomez F., Berman R.F. Amygdala kindled seizure stage is related to altered benzodiazepine binding site density. Life Sci. 36:1984;183-190.
21. Tietz E.I., Rosenberg H.C., Chiu T.H. A comparison of the anticonvulsant effects of 1,4- and 1,5-benzodiazepines in the amygdala-kindled rat and their effects on motor function. Epilepsy Res. 3:1989;31-40.
22. Venault P., Chapoutier G., De Carvalho L.P., Simiand J., Morre M., Dodd R.H., Rossier J. Benzodiazepines impair and beta-carbolines enhance performance in learning and memory tasks. Nature. 321:1986;864-866.
23. Żarnowski T., Kleinrok Z., Turski W.A., Czuczwar S.J. 2,3-Dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptics drugs against maximal electroshock-induced seizures in mice. Neuropharmacology. 32:1993;895-900.